Cargando…
Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus
Plasma B-type natriuretic peptide (BNP) is a useful marker for diagnosis of hemodynamically significant PDA (hsPDA) and serial BNP measurement is also valuable for monitoring treatment response. This retrospective study was performed to evaluate whether plasma BNP level can predict treatment respons...
Autores principales: | Oh, Seong Hee, Lee, Byong Sop, Jung, Euiseok, Oh, Moon Yeon, Do, Hyun-Jeong, Kim, Ellen Ai-Rhan, Kim, Ki-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064477/ https://www.ncbi.nlm.nih.gov/pubmed/32157119 http://dx.doi.org/10.1038/s41598-020-61291-w |
Ejemplares similares
-
Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment
por: Yoo, Hani, et al.
Publicado: (2017) -
Single-dose prophylactic ibuprofen therapy for patent ductus arteriosus in preterm infants
por: Kim, Chae Young, et al.
Publicado: (2022) -
Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus
por: Engbers, Aline G.J., et al.
Publicado: (2020) -
Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newborns
por: Flint, Robert B., et al.
Publicado: (2018) -
The Effect of Ibuprofen Exposure and Patient Characteristics on the Closure of the Patent Ductus Arteriosus in Preterm Infants
por: Engbers, Aline G. J., et al.
Publicado: (2022)